S557-0231 Screening compound: N-benzyl-2-({1-[(3,4-dimethoxyphenyl)methyl]azetidin-3-yl}oxy)benzamide

S557-0231 Screening compound: N-benzyl-2-({1-[(3,4-dimethoxyphenyl)methyl]azetidin-3-yl}oxy)benzamide
S557-0231 Screening compound: N-benzyl-2-({1-[(3,4-dimethoxyphenyl)methyl]azetidin-3-yl}oxy)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S557-0231
N-benzyl-2-({1-[(3,4-dimethoxyphenyl)methyl]azetidin-3-yl}oxy)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S557-0231

Molecular Formula

C26H28N2O4 (C26 H28 N2 O4)

Compound Name

N-benzyl-2-({1-[(3,4-dimethoxyphenyl)methyl]azetidin-3-yl}oxy)benzamide

IUPAC name

N-benzyl-2-({1-[(34-dimethoxyphenyl)methyl]azetidin-3-yl}oxy)benzamide

SMILES

COc(ccc(CN(C1)CC1Oc(cccc1)c1C(NCc1ccccc1)=O)c1)c1OC

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

432.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.569

Distribution Coefficient, logD

0.574

Water Solubility, LogSw

-3.83

Polar Surface Area

50.191

Acid Dissociation Constant (pKa)

10.42

Base Dissociation Constant (pKb)

10.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.92

S557-0231 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

CNS Targets (44014 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Proline Kinase Library (2105 compounds)

Protein-Protein Interaction Library (218420 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Nervous system
  • Cancer
  • Digestive system
  • Nervous system
  • Male
  • Female
  • Endocrine
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
  • Ion Channels
  • Kinases
  • Kinases
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S557-0231 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S557-0231?
Check Price and Availability of S557-0231, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S557-0231 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S557-0231
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S557-0231
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S557-0231 available by request